Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Megan M. Herr"'
Autor:
Maximilian Merz, Almuth Maria Anni Merz, Jie Wang, Lei Wei, Qiang Hu, Nicholas Hutson, Cherie Rondeau, Kimberly Celotto, Ahmed Belal, Ronald Alberico, AnneMarie W. Block, Hemn Mohammadpour, Paul K. Wallace, Joseph Tario, Jesse Luce, Sean T. Glenn, Prashant Singh, Megan M. Herr, Theresa Hahn, Mehmet Samur, Nikhil Munshi, Song Liu, Philip L. McCarthy, Jens Hillengass
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-15 (2022)
Osteolytic lesions (OL) are frequent in multiple myeloma (MM), but are poorly understood. Here, the authors characterise OLs in MM patient samples using single-cell RNA-seq, revealing genes that are specifically regulated in OL compared to random bon
Externí odkaz:
https://doaj.org/article/f796828f91bf49deafc2d56948663af8
Autor:
Abhay Singh, Megan M. Herr, Elizabeth A. Griffiths, Amanda Przespolewski, Mark G. Faber, Chebli Mrad, Eunice S. Wang, Theresa Hahn, Swapna Thota
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Clonal hematopoiesis (CH) is a risk factor for the development of therapy-related myelodysplastic syndromes (tMDS) and acute myeloid leukemia (tAML). Adoption of targeted-immunotherapeutics since 2011, may alter the risk of CH progression to
Externí odkaz:
https://doaj.org/article/ad170899005a44ae897c0ca8999eacac
Autor:
Megan M. Herr, Sara J. Schonfeld, Graça M. Dores, Eric A. Engels, Margaret A. Tucker, Rochelle E. Curtis, Lindsay M. Morton
Publikováno v:
Blood Advances, Vol 3, Iss 13, Pp 1961-1969 (2019)
Abstract: Infectious agents have been identified in the etiology of certain non-Hodgkin lymphoma (NHL) subtypes and solid tumors. The impact of this shared etiology on risk for second cancers in NHL survivors has not been comprehensively studied. We
Externí odkaz:
https://doaj.org/article/5740ab443da74f24bcc622eba33ee568
Autor:
Paul K. Wallace, Lei Wei, Philip L. McCarthy, Theresa Hahn, Almuth Maria Anni Merz, Jesse Luce, Qiang Hu, Prashant Singh, Maximilian Merz, Megan M. Herr, Song Liu, Ahmed Belal, Ronald A. Alberico, Joseph D. Tario, AnneMarie W. Block, Cherie Rondeau, Kelvin P. Lee, Hemn Mohammadpour, Sean T. Glenn, Jens Hillengass, Kimberly Celotto, Jie Wang
Publikováno v:
Blood Advances. 7:718-733
Introduction: Therapy and immune mediated processes are associated with clonal evolution in multiple myeloma (MM). In this study, we performed whole-exome sequencing (WES) and single cell RNA sequencing (scRNA-seq) on plasma cells (PC) from bone marr
Autor:
Paul K. Wallace, Joseph D. Tario, Philip L. McCarthy, AnneMarie W. Block, Jens Hillengass, Ahmed Belal, Mehmet Kemal Samur, Cherie Rondeau, Jesse Luce, Maximilian Merz, Hemn Mohammadpour, Theresa Hahn, Lei Wei, Almuth Maria Anni Merz, Sean T. Glenn, Song Liu, Kimberly Celotto, Jie Wang, Nicholas Hutson, Prashant Singh, Megan M. Herr, Qiang Hu, Ronald A. Alberico, Nikhil C. Munshi
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-15 (2022)
Osteolytic lesions (OL) characterize symptomatic multiple myeloma. The mechanisms of how malignant plasma cells (PC) cause OL in one region while others show no signs of bone destruction despite subtotal infiltration remain unknown. We report on a si
Autor:
Amanda Przespolewski, Megan M. Herr, Elizabeth A. Griffiths, Mark G. Faber, Eunice S. Wang, Swapna Thota, Abhay Singh, Theresa Hahn, Chebli Mrad
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Scientific Reports
Scientific Reports
Clonal hematopoiesis (CH) is a risk factor for the development of therapy-related myelodysplastic syndromes (tMDS) and acute myeloid leukemia (tAML). Adoption of targeted-immunotherapeutics since 2011, may alter the risk of CH progression to tMDS/AML
Autor:
Neel S. Bhatt, Akshay Sharma, Andrew St. Martin, Muhammad Bilal Abid, Valerie I. Brown, Miguel Angel Diaz Perez, Haydar Frangoul, Shahinaz M. Gadalla, Megan M. Herr, Maxwell M. Krem, Hillard M. Lazarus, Michael J. Martens, Parinda A. Mehta, Taiga Nishihori, Tim Prestidge, Michael A. Pulsipher, Hemalatha G. Rangarajan, Kirsten M. Williams, Lena E. Winestone, Dwight E. Yin, Marcie L. Riches, Christopher E. Dandoy, Jeffery J. Auletta
Publikováno v:
Transplantation and cellular therapy, vol 28, iss 10
Adult hematopoietic stem cell transplantation (HSCT) recipients are at a high risk of adverse outcomes after COVID-19. Although children have had better outcomes after COVID-19 compared to adults, data on risk factors and outcomes of COVID-19 among p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7844523a39e4bd68f0d113b54cda10b
https://escholarship.org/uc/item/3sv0j8f1
https://escholarship.org/uc/item/3sv0j8f1
Critically Ill Patients Treated for Chimeric Antigen Receptor-Related Toxicity: A Multicenter Study*
Autor:
Megan M. Herr, Cristina Gutierrez, Anne Rain T. Brown, Alejandro S. Arias, Lei Feng, Elena Mead, Amer Beitinjaneh, Yi Lin, Monalisa Ghosh, Ananda Dharshan, Agrima Mian, Janhavi Athale, Prabalini Rajendram, Joseph L. Nates, Jason R. Westin, R. Scott Stephens, Natalie Kostelecky, Colleen McEvoy, James N. Kochenderfer, Alice Gallo De Moraes, Heather P. May, Matthew K. Hensley, Jennifer N. Brudno, Stephen M. Pastores
Publikováno v:
Critical Care Medicine. 50:81-92
Objectives To report the epidemiology, treatments, and outcomes of adult patients admitted to the ICU after cytokine release syndrome or immune effector cell-associated neurotoxicity syndrome. Design Retrospective cohort study SETTING:: Nine centers
Publikováno v:
Blood. 140:934-935
Autor:
Steven G.E. Marsh, Dipenkumar Modi, Yvette L. Kasamon, Shahinaz M. Gadalla, Effie W. Petersdorf, Michelle Kuxhausen, Stephen R. Spellman, Shannon R. McCurdy, Scott R. Solomon, Michael R. Grunwald, Sophie Paczesny, Stephanie Fingerson, Asad Bashey, Ephraim J. Fuchs, Taiga Nishihori, Caroline McKallor, Bronwen E. Shaw, Joseph P. McGuirk, Stephanie J. Lee, Tao Wang, Megan M. Herr, Ayman Saad, Yung-Tsi Bolon
Publikováno v:
Blood
Hematopoietic cell transplantation from HLA-haploidentical related donors is increasingly used to treat hematologic cancers; however, characteristics of the optimal haploidentical donor have not been established. We studied the role of donor HLA mism
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4a25019408062418c218e689faacd7a
https://europepmc.org/articles/PMC8914182/
https://europepmc.org/articles/PMC8914182/